CD44 and neoplasm: Accordingly, tumors of Bio-nFeR-treated mice showed a contraction of the CD44+/CD24− population, a reduced expression of stem cell-associated ALDH1, lower content of colony-forming units, and decreased frequency of tumor-initiating cells upon second transplantation in immunocompromised mice.